Overview

CBRE’s Bay Area Life Science team has been designed and assembled to specifically address the real estate strategies of life science companies in the greater Northern California region. Our immersion in the life science market over the past few decades, along with the diverse backgrounds and unique knowledge and skills of our team members, allows us to offer a variety of comprehensive client services; we connect business needs with capital expenditures while managing real estate risk. These services include strategic planning, market analysis, expert negotiations, and project management – collectively preparing our clients to leverage opportunities.

Together with the synergy of our group, our collective experiences and institutional knowledge have made us the most experienced and successful life science team in the San Francisco Bay Area.

Significant Transactions

 

 

 Address  Size
 1635 Rollins Road, Burlingame ±200,000 SF
 5000 Shoreline Court, South San Francisco ±140,000 SF
 South SF Business Center ±112,000 SF
 Foretalk Communications ±47,000 SF
 JFC International ±240,000 SF 
 Zymed Laboratories ±58,000 SF
 Gateway North Campus ±450,000 SF
 AGY Therapeutics ±105,000 SF 
 EOS Biotechnology ±85,000 SF
 Intermune, Inc. ±55,000 SF
 MJ Bioworks ±140,000 SF
 Gateway North Campus  ±450,000 SF
 Renovis Neuroscience ±20,000 SF
 Woodside Technology Center  ±254,000 SF
 Grand Business Park ±340,000 SF
 The Gateway ±450,000 SF
 Hilltop Business Center ±141,000 SF
 Littlefield Center ±325,000 SF
 1640 Rollins Center ±225,00 SF

 

Let us transform your real estate into real advantage. View our available properties and connect with us today.
Find Our Listings

Clients Represented

 

  • Abbott Laboratories
  • AGY Therapeutics
  • Alza
  • Alliance Pharmaceutical
  • Amgen
  • Applied Genetics
  • Applied Immune Systems
  • Argonaut Technologies
  • Axon Instruments
  • Baxter Health Care
  • Binding Site
  • Biochain Institute
  • BioManagement Group
  • Biocheck, Inc.
  • Biometric Imaging
  • Bioprogress Technology
  • Bioproxis
  • Bio-Science Contract Production
  • BioVenture Consultants
  • Bracco Research
  • Bristol Myers Squibb
  • Cadus Pharmaceuticals
  • Cambrex
  • Canji
  • Cardima
  • Cardinal Health
  • Cato Research
  • Celgene
  • Cetus Immune
  • Chiragene
  • Chiron
  • Choloestech
  • Conceptus
  • COR Therapeutics
  • Cortex
  • Corvas International
  • Cygnus Therapeutics Systems
  • Cyrtometry Research Associates
  • DNA Plant Technology
  • DNAX/Schering Plough
  • DuPont
  • Enamelon
  • Enzon
  • Eisai Pharmaceutical
  • Elan Pharmaceuticals
  • Epigenesis
  • EOS Biotechnology
  • Five Prime Therapeutics
  • Forest Laboratories
  • Genelabs
  • Genprobe Systems
  • Gilead Sciences
  • Glycomed
  • Hoffmann-LaRoche
  • Icon Genetics
  • ICN Pharmaceuticals
  • Idon
  • Immunomedics
  • Immusol
  • Inpro Biotechnology
  • Insite Vision
  • Intermune, Inc.
  • Invitrogen
  • Kissei Pharmaceutical
  • LabCorp
  • Lynx Therapeutics
  • Martin Marietta
  • MedImune, Inc.
  • Medix Biotech
  • Membrane Technology
  • Merck
  • Metricka
  • Mizoho USA
  • Millennium Pharmaceuticals
  • MJ Research
  • Molecular Biosystems
  • Mycogen
  • Nanogen
  • Neurocrine Biosciences
  • NJEDA
  • Oral-B Laboratories
  • Ortho Biotech
  • Pace Labs
  • Parke Davis-Warner Lambert
  • Penta Biotech
  • Praecis Pharmaceuticals
  • Prolink Biotechnologies
  • Raven Biotechnology
  • Repligen
  • Royce BioMedical
  • Searle
  • Sequus Pharmaceuticals
  • Signal Pharmaceuticals
  • Somagenics
  • Sterigenics
  • Synergen
  • Synthon Corporation
  • Systemix
  • Target Therapeutics
  • Terra Labs/Perceptive Scientific
  • Transcell Laboratories
  • Transplant Therapeutics
  • Univax Biologics
  • Vical
  • Vaxgen
  • VistaGen
  • Whitaker-Scientic
  • Wyeth-Ayerst
  • Zeneca